Showing 1 - 2 results of 2 for search 'H. Lambers Heerspink', query time: 0.02s Refine Results
  1. 1
    POS-831 THE EFFECT OF DAPAGLIFLOZIN IN PATIENTS WITH eGFR <30 mL/min/1.73m2: FINDINGS FROM THE DAPA-CKD TRIAL

    POS-831 THE EFFECT OF DAPAGLIFLOZIN IN PATIENTS WITH eGFR <30 mL/min/1.73m2: FINDINGS FROM THE DAPA-CKD TRIAL by G.M. Chertow, P. Vart, N. Jongs, R.D. Toto, J.L. Gorriz, F.F. Hou, J.J.V. McMurray, R. Correa-Rotter, P. Rossing, C.D. Sjöström, B.V. Stefánsson, A.M. Langkilde, D.C. Wheeler, H. Lambers Heerspink

    Published 2021-04-01
    Get full text
    Article
  2. 2
    POS-832 DAPAGLIFLOZIN IN IgA NEPHROPATHY: FINDINGS FROM THE DAPA-CKD TRIAL

    POS-832 DAPAGLIFLOZIN IN IgA NEPHROPATHY: FINDINGS FROM THE DAPA-CKD TRIAL by H. Lambers Heerspink, R.D. Toto, N. Jongs, P. Vart, G.M. Chertow, F.F. Hou, J.J.V. McMurray, R. Pecoits-Filho, R. Correa-Rotter, P. Rossing, C.D. Sjöström, B.V. Stefánsson, K. Umanath, A.M. Langkilde, D.C. Wheeler

    Published 2021-04-01
    Get full text
    Article

Search Tools: